This program will provide U.S. and European perspectives on intellectual property considerations for use of artificial intelligence ("AI") in the lifecycle of biopharmaceutical products. Specific topics will include AI networks and tools, the AI-biopharma space, patent portfolio considerations, and IP transactional considerations. We hope you will be able to participate in this timely webinar. This program has been approved for 1.00 hour of general distance learning credit by the Pennsylvania CLE Board. This program has also been approved for 1.00 hour of general credit by the State Bar of California and 1.00 hour of areas of professional practice credit (including transitional) by the New York State CLE Board.